New York Life Investment Management LLC, along with several other firms, have boosted their positions in Amcor Plc (AMCR), indicating increased interest in the company. Notably, JPMorgan initiated coverage on Amcor with an 'Overweight' rating and a $10.00 price target. However, Wells Fargo) lowered their price target for Amcor to $9, while maintaining their 'Overweight' rating. In the market, Amcor's stock has seen some fluctuation, with a surge that led to speculation about its sustainability, and then reaching a new 1-year low. The company has also reported strong Q4 results, which are expected to drive growth in the future. Despite missing EPS estimates by 46%, Amcor's CFO transition and launch of a healthcare packaging solution are viewed positively. Finally, Stifel turned bullish on Amcor, also citing strong synergy potential, as the company plans an expansion in Europe. However, it's noted that while the past three years have not been profitable for investors, Amcor remains a dividend aristocrat.
Amcor Plcs AMCR News Analytics from Mon, 03 Mar 2025 08:00:00 GMT to Sat, 01 Nov 2025 17:19:30 GMT - Rating 2 - Innovation 6 - Information 8 - Rumor -6
